JP2008527027A5 - - Google Patents

Download PDF

Info

Publication number
JP2008527027A5
JP2008527027A5 JP2007551725A JP2007551725A JP2008527027A5 JP 2008527027 A5 JP2008527027 A5 JP 2008527027A5 JP 2007551725 A JP2007551725 A JP 2007551725A JP 2007551725 A JP2007551725 A JP 2007551725A JP 2008527027 A5 JP2008527027 A5 JP 2008527027A5
Authority
JP
Japan
Prior art keywords
synthase
leukotriene
mpges
activating protein
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007551725A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008527027A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2005/004978 external-priority patent/WO2006077364A1/en
Publication of JP2008527027A publication Critical patent/JP2008527027A/ja
Publication of JP2008527027A5 publication Critical patent/JP2008527027A5/ja
Withdrawn legal-status Critical Current

Links

JP2007551725A 2005-01-19 2005-12-22 炎症の治療に有用なインドール類 Withdrawn JP2008527027A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64455405P 2005-01-19 2005-01-19
US64455305P 2005-01-19 2005-01-19
PCT/GB2005/004978 WO2006077364A1 (en) 2005-01-19 2005-12-22 Indoles useful in the treatment of inflammation

Publications (2)

Publication Number Publication Date
JP2008527027A JP2008527027A (ja) 2008-07-24
JP2008527027A5 true JP2008527027A5 (https=) 2009-02-19

Family

ID=36001052

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007551725A Withdrawn JP2008527027A (ja) 2005-01-19 2005-12-22 炎症の治療に有用なインドール類

Country Status (7)

Country Link
US (1) US20080249091A1 (https=)
EP (1) EP1844013A1 (https=)
JP (1) JP2008527027A (https=)
AR (1) AR053993A1 (https=)
CA (1) CA2594878A1 (https=)
TW (1) TW200637820A (https=)
WO (1) WO2006077364A1 (https=)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2315877T3 (es) * 2004-06-18 2009-04-01 Biolipox Ab Indoles utiles en el tratamiento de inflamaciones.
AU2005254783A1 (en) * 2004-06-18 2005-12-29 Biolipox Ab Indoles useful in the treatment of inflammation
US20080146616A1 (en) * 2004-06-18 2008-06-19 Kristofer Olofsson Indoles Useful in the Treatment of Inflammation
JP2008527030A (ja) * 2005-01-19 2008-07-24 バイオリポックス エービー 炎症の治療に有用なインドール類
CN101142185A (zh) 2005-01-19 2008-03-12 比奥里波克斯公司 用于炎症治疗的吲哚
US7977359B2 (en) 2005-11-04 2011-07-12 Amira Pharmaceuticals, Inc. 5-lipdxygenase-activating protein (FLAP) inhibitors
GB2431927B (en) 2005-11-04 2010-03-17 Amira Pharmaceuticals Inc 5-Lipoxygenase-activating protein (FLAP) inhibitors
US8399666B2 (en) 2005-11-04 2013-03-19 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
WO2008009924A2 (en) * 2006-07-18 2008-01-24 Biolipox Ab Indoles useful in the treatment of inflammation
CN101157688B (zh) * 2006-10-16 2010-09-08 复旦大学 6-苄氧基吲哚-2-甲酸糠醇酯衍生物及其制备方法和用途
US8293781B2 (en) 2007-03-29 2012-10-23 Daiichi Sankyo Company, Limited Indole derivatives having cPLA2 inhibiting activity and applications and production methods of the same
TW200920369A (en) 2007-10-26 2009-05-16 Amira Pharmaceuticals Inc 5-lipoxygenase activating protein (flap) inhibitor
MX2010012814A (es) 2008-05-23 2010-12-20 Amira Pharmaceuticals Inc Inhibidor de proteina activadora de 5-lipoxigenasa.
US8546431B2 (en) 2008-10-01 2013-10-01 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
WO2010071865A1 (en) 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
US20100160351A1 (en) * 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
US20120029016A1 (en) 2008-12-30 2012-02-02 Biolipox Ab Indoles Useful in the Treatment of Inflammation
AR077214A1 (es) 2009-06-24 2011-08-10 Neurocrine Biosciences Inc Heterociclos nitrogenados y composiciones farmaceuticas que los contienen
AU2010264720A1 (en) 2009-06-24 2011-12-08 Boehringer Ingelheim International Gmbh New compounds, pharmaceutical composition and methods relating thereto
JP2012211085A (ja) * 2009-08-12 2012-11-01 Kyowa Hakko Kirin Co Ltd ヘッジホッグシグナル阻害剤
WO2011032175A1 (en) 2009-09-14 2011-03-17 Nuon Therapeutics, Inc. Combination formulations of tranilast and allopurinol and methods related thereto
GB201006846D0 (en) 2010-04-23 2010-06-09 Glaxo Group Ltd Novel compounds
EP3388441A1 (en) 2012-12-18 2018-10-17 Vertex Pharmaceuticals Incorporated Mannose derivatives for treating bacterial infections
MX2015012472A (es) 2013-03-12 2016-02-10 Vertex Pharma Derivados de manosa para el tratamiento de infecciones bacterianas.
US10351532B2 (en) 2014-12-29 2019-07-16 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Small molecule inhibitors of lactate dehydrogenase and methods of use thereof
EP3241830A1 (de) 2016-05-04 2017-11-08 Bayer CropScience Aktiengesellschaft Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel
CA3026149A1 (en) 2016-06-02 2017-12-07 Cadent Therapeutics, Inc. Potassium channel modulators
SI3571193T1 (sl) 2017-01-23 2022-04-29 Cadent Therapeutics, Inc. Modulatorji kalijevega kanalčka
CN108892604B (zh) * 2018-08-15 2022-05-31 江西师范大学 一种制备卤代苯并[b]芴酮系列化合物的方法
CA3116339A1 (en) 2018-10-22 2020-04-30 Cadent Therapeutics, Inc. Crystalline forms of potassium channel modulators
CN109665985B (zh) * 2018-11-30 2020-09-29 中国科学院广州生物医药与健康研究院 多取代吲哚类化合物及其应用
BR112021013557A2 (pt) 2019-01-11 2021-09-21 Grünenthal GmbH Amidas de pirrolidina substituídas iii
CN110804059B (zh) * 2019-09-30 2024-03-12 郑州泰基鸿诺医药股份有限公司 氨基甲酸酯类化合物、药物组合物及其应用
PY2112437A (es) 2020-02-18 2022-08-16 Bayer Ag Nuevos compuestos de heteroaril-triazol como pesticidas

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5081138A (en) * 1986-12-17 1992-01-14 Merck Frosst Canada, Inc. 3-hetero-substituted-n-benzyl-indoles and prevention of leucotriene synthesis therewith
US4960786A (en) * 1989-04-24 1990-10-02 Merrell Dow Pharmaceuticals Inc. Excitatory amino acid antagonists
US5081145A (en) * 1990-02-01 1992-01-14 Merck Frosst Canada, Inc. Indole-2-alkanoic acids compositions of and anti allergic use thereof
US5374615A (en) * 1990-10-31 1994-12-20 E. R. Squibb & Sons, Inc. Indole- and benzimidazole-substituted imidazole and benzimidazole derivatives
US5189054A (en) * 1990-11-02 1993-02-23 Merrell Dow Pharmaceuticals Inc. 3-amidoindolyl derivatives and pharmaceutical compositions thereof
US5294722A (en) * 1992-04-16 1994-03-15 E. R. Squibb & Sons, Inc. Process for the preparation of imidazoles useful in angiotensin II antagonism
US5236916A (en) * 1992-05-26 1993-08-17 E. R. Squibb & Sons, Inc. Oxadiazinone substituted indole and benzimidazole derivatives
TW229140B (https=) * 1992-06-05 1994-09-01 Shell Internat Res Schappej B V
JPH10510510A (ja) * 1994-06-09 1998-10-13 スミスクライン・ビーチャム・コーポレイション エンドセリン受容体拮抗物質
US6630496B1 (en) * 1996-08-26 2003-10-07 Genetics Institute Llc Inhibitors of phospholipase enzymes
GB9716656D0 (en) * 1997-08-07 1997-10-15 Zeneca Ltd Chemical compounds
GB9716657D0 (en) * 1997-08-07 1997-10-15 Zeneca Ltd Chemical compounds
DK1042287T3 (da) * 1997-12-24 2005-08-15 Aventis Pharma Gmbh Indolderivater som inhibitorer af faktor Xa
GB9803228D0 (en) * 1998-02-17 1998-04-08 Zeneca Ltd Chemical compounds
HUP0100156A3 (en) * 1998-02-25 2002-12-28 Genetics Inst Inc Cambridge Indole derivatives as inhibitors of phospholipase a2 and use of them for producing pharmaceutical compositions
US6828344B1 (en) * 1998-02-25 2004-12-07 Genetics Institute, Llc Inhibitors of phospholipase enzymes
US6500853B1 (en) * 1998-02-28 2002-12-31 Genetics Institute, Llc Inhibitors of phospholipase enzymes
GB9902453D0 (en) * 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
GB9902452D0 (en) * 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
GB9902455D0 (en) * 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
JP2001069477A (ja) * 1999-08-31 2001-03-16 Sony Corp 番組提供システム及び番組提供方法
US6353007B1 (en) * 2000-07-13 2002-03-05 Boehringer Ingelheim Pharmaceuticals, Inc. Substituted 1-(4-aminophenyl)indoles and their use as anti-inflammatory agents
AU2002211901A1 (en) * 2000-10-10 2002-04-22 Smithkline Beecham Corporation Substituted indoles, pharmaceutical compositions containing such indoles and their use as PPAR-gamma binding agents
US20090042949A1 (en) * 2005-01-19 2009-02-12 Benjamin Pelcman Indoles Useful in the Treatment of Inflammation

Similar Documents

Publication Publication Date Title
JP2008527027A5 (https=)
JP2008527030A5 (https=)
JP2008527028A5 (https=)
JP2008527032A5 (https=)
JP2008527031A5 (https=)
WO2007022501A3 (en) Useful indole compounds
WO2008048991A3 (en) Organic compounds
WO2007126957A3 (en) New compounds
EA200970996A1 (ru) Стволовые клеточные линии, полученные из эмбрионов утки, для производства вирусных вакцин
NO20091926L (no) Anti-Notch3-agonist-antistoffer og deres anvendelse ved behandlingen av Notch3-relaterte sykdommer
BRPI0816116A2 (pt) Derivados de indol 2,3-substituídos para o tratamento de infecções virais.
EP1954683A4 (en) 2- (PHENYL OR HETEROCYCLYL) -1H-PHENANTHRO (9,10-D) IMIDAZOLE AS MPGES-1 INHIBITORS
EA201791541A3 (ru) Композиции и способы контроля нематод
ATE530521T1 (de) Hemmer des 5-lipoxygenase aktivierenden proteins (flap)
DK1948678T3 (da) Forbindelser til enzyminhibering
ATE428770T1 (de) Verstärkte reaktivierung wärmebeständiger, reversibel inaktivierter enzyme
BRPI0607742A2 (pt) moduladores de fenil e piridil lta4h
NO20076515L (no) Hydantoinforbindelser
WO2006128142A8 (en) Inhibitors of cytosolic phospholipase a2
MY144970A (en) Heterocyclic compounds
EA200702430A1 (ru) Модифицированные микроорганизмы с инактивированным геном лактатдегидрогеназы
DE602006015671D1 (de) Kokumi-geschmackverbindungen und ihre verwendung
JP2005330486A5 (https=)
ATE497779T1 (de) Enzyme zur reduzierung von immunologischem stress
WO2006122090A3 (en) Screening assays for compounds regulating dj-i expression